Transition probabilities of HER2-positive and HER2-negative breast cancer patients treated with Trastuzumab obtained from a clinical cancer registry dataset

Por Pobiruchin, Monika, Bochum, Sylvia, Martens, Uwe M., Kieser, Meinhard, Schramm, Wendelin
Publicado no Data Brief (2016)

Telomeres in the mouse have large inter-chromosomal variations in the number of T(2)AG(3) repeats

Por Zijlmans, J. Mark J. M., Martens, Uwe M., Poon, Steven S. S., Raap, Anton K., Tanke, Hans J., Ward, Rabab K., Lansdorp, Peter M.
Publicado em 1997

XXIII International Association for Comparative Research on Leukemia and Related Diseases Symposium: from Molecular Pathogenesis to Targeted Therapy in Leukemia and Solid Tumors

Por Hackanson, Björn, Becker, Heiko, Berg, Tobias, Binder, Mascha, Dierks, Christine, Duque-Afonso, Jesús, Lairmore, Michael D., Schäfer, Henning S., Schnitzler, Marc, Zeiser, Robert, Martens, Uwe, Mertelsmann, Roland, Lübbert, Michael
Publicado em 2008

A highly selective telomerase inhibitor limiting human cancer cell proliferation

Por Damm, Klaus, Hemmann, Ulrike, Garin-Chesa, Pilar, Hauel, Norbert, Kauffmann, Iris, Priepke, Henning, Niestroj, Claudia, Daiber, Christine, Enenkel, Barbara, Guilliard, Bernd, Lauritsch, Ines, Müller, Elfriede, Pascolo, Emanuelle, Sauter, Gabriele, Pantic, Milena, Martens, Uwe M., Wenz, Christian, Lingner, Joachim, Kraut, Norbert, Rettig, Wolfgang J., Schnapp, Andreas
Publicado em 2001